These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17510303)

  • 1. High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.
    Kam RK; Poon TC; Chan HL; Wong N; Hui AY; Sung JJ
    Clin Chem; 2007 Jul; 53(7):1254-63. PubMed ID: 17510303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study.
    Poon TC; Hui AY; Chan HL; Ang IL; Chow SM; Wong N; Sung JJ
    Clin Chem; 2005 Feb; 51(2):328-35. PubMed ID: 15590748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis B.
    Qu Y; Gao CF; Zhou K; Zhao YP; Xu MY; Lu LG
    Ann Hepatol; 2012; 11(2):202-12. PubMed ID: 22345337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.
    Ressom HW; Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R
    J Proteome Res; 2008 Feb; 7(2):603-10. PubMed ID: 18189345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
    Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
    Park CW; Jo Y; Jo EJ
    Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered serum N-glycomics in chronic hepatitis B patients.
    Gui HL; Gao CF; Wang H; Liu XE; Xie Q; Dewaele S; Wang L; Zhuang H; Contreras R; Libert C; Chen C
    Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS.
    Karatayli SC; Alagöz SG; Mizrak D; Sayki M; Ozkan M; Savaş B; Erden E; Cinar K; Idılman R; Yurdaydin C; Bozdayi AM
    Turk J Gastroenterol; 2012 Feb; 23(1):46-53. PubMed ID: 22505379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
    Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
    Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics.
    Kobayashi T; Ogawa K; Furukawa JI; Hanamatsu H; Hato M; Yoshinaga T; Morikawa K; Suda G; Sho T; Nakai M; Higashino K; Numata Y; Shinohara Y; Sakamoto N
    J Proteome Res; 2019 Aug; 18(8):3133-3141. PubMed ID: 31266306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers.
    Ressom HW; Varghese RS; Goldman L; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Goldman R
    Pac Symp Biocomput; 2008; ():216-27. PubMed ID: 18229688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS.
    Qin W; Zhang Z; Qin R; Han J; Zhao R; Gu Y; Pan Y; Gu J; Ren S
    Anal Chim Acta; 2019 Nov; 1081():112-119. PubMed ID: 31446948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dried blood spot N-glycome analysis by MALDI mass spectrometry.
    Vreeker GCM; Bladergroen MR; Nicolardi S; Mesker WE; Tollenaar RAEM; van der Burgt YEM; Wuhrer M
    Talanta; 2019 Dec; 205():120104. PubMed ID: 31450448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.
    Göbel T; Vorderwülbecke S; Hauck K; Fey H; Häussinger D; Erhardt A
    World J Gastroenterol; 2006 Dec; 12(47):7604-12. PubMed ID: 17171788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative glycomic profiling in esophageal adenocarcinoma.
    Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
    Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ascites N-glycome of epithelial ovarian cancer patients.
    Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
    J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.